Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
2017553 citationsJennifer L. Taylor‐Cousar, À. Munck et al.New England Journal of Medicineprofile →
VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
2018500 citationsD. Keating, Gautham Marigowda et al.New England Journal of Medicineprofile →
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
2017364 citationsSteven M. Rowe, Cori Daines et al.New England Journal of Medicineprofile →
Selective Inhibition of Na V 1.8 with VX-548 for Acute Pain
2023110 citationsJ. W. Jones, Darin Correll et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Simard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Simard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Simard more than expected).
This network shows the impact of papers produced by C Simard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Simard. The network helps show where C Simard may publish in the future.
Co-authorship network of co-authors of C Simard
This figure shows the co-authorship network connecting the top 25 collaborators of C Simard.
A scholar is included among the top collaborators of C Simard based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Simard. C Simard is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Jones, J. W., Darin Correll, Sandra Lechner, et al.. (2023). Selective Inhibition of Na V 1.8 with VX-548 for Acute Pain. New England Journal of Medicine. 389(5). 393–405.110 indexed citations breakdown →
Keating, D., Gautham Marigowda, Lucy Burr, et al.. (2018). VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. New England Journal of Medicine. 379(17). 1612–1620.500 indexed citations breakdown →
Taylor‐Cousar, Jennifer L., À. Munck, Edward F. McKone, et al.. (2017). Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. New England Journal of Medicine. 377(21). 2013–2023.553 indexed citations breakdown →
10.
Rowe, Steven M., Cori Daines, Felix C. Ringshausen, et al.. (2017). Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis. New England Journal of Medicine. 377(21). 2024–2035.364 indexed citations breakdown →
11.
Verret, J L, et al.. (1983). Pigmentation cutanée induite par la minocycline.. Annales de Dermatologie et de Vénéréologie. 110(9).2 indexed citations
12.
Simard, C, et al.. (1983). [Skin pigmentation induced by minocycline].. PubMed. 110(9). 777–8.2 indexed citations
13.
Saint‐André, Jean‐Paul, et al.. (1983). [Chronic atrophic gastritis with carcinoid tumor and microcarcinoidosis. Report of a case with immunohistochemistry and ultrastructure study].. PubMed. 3(3). 235–40.6 indexed citations
14.
Simard, C, et al.. (1982). [Could isolated mesangial deposits of C3 be responsible of glomerular hematuric nephropathies (author's transl)].. PubMed. 2(2). 159–62.1 indexed citations
15.
Perreau, P., et al.. (1972). [Gougerot-Sjögren syndrome and glomerulonephritis].. PubMed. 48(14). 973–8.2 indexed citations
16.
Perreau, P., et al.. (1972). [Primary lithiasis of the small intestine and intestinal tuberculosis].. PubMed. 48(41). 2665–7.
17.
Pillot, J, et al.. (1971). [Histological study of hepatitis observed during treatment with rifampicin (comparison with the results of research on the Australia antigen)].. PubMed. 35(2). 185–96.
18.
Simard, C, et al.. (1970). [Pulmonary allescheriasis (mycetoma due to Allescheria boydii)].. PubMed. 22(4). 425–37.3 indexed citations
19.
Simard, C, et al.. (1968). [Coexistent reticulum cell sarcoma and chronic myeloid leukemia].. PubMed. 76(4). 169–72.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.